To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects

NCT06485401 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Type A
Influenza Type B

Interventions

DRUG: ADC189

Sponsor

Jiaxing AnDiCon Biotech Co.,Ltd